Transthoracic Drainage of Lung Abscesses. A National Randomized Trial.

This study aims to investigate if early drainage of lung abscesses, in addition to standard antibiotic treatment, leads to shorter length of hospital stay. Study Design This is a randomized, controlled clinical trial. That means participants will be randomly assigned to one of two groups: 1. Drainage group: Receives a chest tube (drain) inserted through the chest wall into the abscess in combination with standard intravenous antibiotics. 2. Control group: Receives standard intravenous antibiotics only Each participant has a 50/50 chance of being placed in either group. During Hospital Stay All participants will begin treatment with intravenous antibiotics (piperacillin/tazobactam). If assigned to the drainage group, a trained medical team will insert a small tube into the abscess to drain the pus. The tube is flushed three times a day with sterile saline. Participants will also: * Fill out two short health questionnaires at the start and during follow-up. * Have relevant medical history collected from their hospital records. * Undergo routine scans (CT), blood tests, and lung assessments as part of standard care. * A cheek swab will be taken from all participants to study mouth bacteria.. For those receiving drainage the pus from the lung abscess will be collected for microbiological analysis. Microbiology samples will be stored in a research biobank and destroyed after analysis. Follow-up after discharge * 1 week: A phone call to check symptoms and infection level…

This description comes directly from the study's public registry record.

Katrine Kristensen, MD  ·  +45 28265001  ·  Karkrs@rm.dk

Always discuss trial participation with your own doctor first.

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.